BlackRock Investment Management’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $4.61M | Buy |
144,619
+9,354
| +7% | +$298K | 0.01% | 1637 |
|
|
2016
Q3 | $4.9M | Sell |
135,265
-184
| -0.1% | -$6.67K | 0.01% | 1494 |
|
|
2016
Q2 | $3.07M | Buy |
135,449
+21,149
| +19% | +$480K | ﹤0.01% | 1787 |
|
|
2016
Q1 | $2.15M | Buy |
114,300
+11,717
| +11% | +$220K | ﹤0.01% | 1946 |
|
|
2015
Q4 | $1.68M | Buy |
102,583
+5,490
| +6% | +$90K | ﹤0.01% | 2214 |
|
|
2015
Q3 | $1.07M | Sell |
97,093
-398
| -0.4% | -$4.37K | ﹤0.01% | 2555 |
|
|
2015
Q2 | $1.27M | Buy |
97,491
+28,420
| +41% | +$370K | ﹤0.01% | 2595 |
|
|
2015
Q1 | $1.2M | Buy |
69,071
+583
| +0.9% | +$10.1K | ﹤0.01% | 2404 |
|
|
2014
Q4 | $1.02M | Sell |
68,488
-525
| -0.8% | -$7.83K | ﹤0.01% | 2532 |
|
|
2014
Q3 | $1.59M | Buy |
69,013
+306
| +0.4% | +$7.05K | ﹤0.01% | 2167 |
|
|
2014
Q2 | $2.19M | Buy |
+68,707
| New | +$2.19M | ﹤0.01% | 2004 |
|